Previous 10 | Next 10 |
2024-06-29 10:00:00 ET Shares of Hims & Hers (NYSE: HIMS) fell on Thursday after a short report was published by a short-seller. This kind of report can often send stocks lower, but is it a reason to panic or a buying opportunity? In this video, Travis Hoium digs into the report...
2024-06-27 15:07:07 ET Shares of online pharmacy Hims & Hers (NYSE: HIMS) dropped as much as 12.8% on Thursday after a short-seller wrote a report about the company. Shares recovered slightly during trading and are down 7.8% at 2:30 p.m. ET today. Hunterbrook Media put o...
2024-06-27 09:36:33 ET More on Hims & Hers Health Hims & Hers: Buy The Dip To Catch The Next Rip Hims & Hers: The Undervalued Gem Poised For Growth Hims & Hers: Compounded Semaglutide Boost Unlikely To Last - Moderate Risks Ahead Hims & He...
2024-06-26 04:23:00 ET Hims & Hers (NYSE: HIMS) has been on a growth tear as it reaches more customers and customizes offerings in ways traditional pharmacies can't. And those advantages open up an enormous market for the company. In this video, Travis Hoium digs into the compet...
2024-06-25 14:07:48 ET More on iShares Russell 2000 ETF: IWM: Small Caps Look Unattractive With Deteriorating Earnings Outlook IWM: Favor Small Caps Over The Technology Sector IWM: Not The Economy For Underdogs (Rating Downgrade) Gap between growth and small-...
2024-06-24 09:37:14 ET Fool.com contributor Parkev Tatevosian evaluates Hims & Hers Health (NYSE: HIMS) stock for long-term investors. *Stock prices used were the afternoon prices of June 20, 2024. The video was published on June 22, 2024. Continue reading ...
2024-06-24 08:30:00 ET Summary After a parabolic run in recent months, HIMS stock took a double-digit plunge last week in an apparent loss of technical momentum. While its technical correction may lead to a deeper pullback in the near term, Hims & Hers' robust business momentu...
2024-06-21 09:44:16 ET More on Hims & Hers Health Hims & Hers: The Undervalued Gem Poised For Growth Hims & Hers: Compounded Semaglutide Boost Unlikely To Last - Moderate Risks Ahead Hims & Hers: Ready For Takeoff Hims & Hers cut to Neutra...
2024-06-20 13:27:30 ET More on iShares Russell 3000 ETF: IWV: Future Performance Will Likely Remain Slightly Inferior To The S&P 500 Index Layoffs mentions by Russell 3000 companies are elevated but trending lower vs history The big risk of AI spending is margin ...
2024-06-18 03:05:48 ET Summary As of this article being written, Hims & Hers Health is up around 33% since the announcement that they will offer GLP-1 Injections for as low as $199 a month. Reports that the company has already started shipping out injections to subscribers. ...
News, Short Squeeze, Breakout and More Instantly...
Hims & Hers Health Inc. Class A Company Name:
HIMS Stock Symbol:
NYSE Market:
Hims & Hers Health Inc. Class A Website:
Bringing experience from Novo Nordisk and Teva Pharmaceutical Industries, Schultz joins the Hims & Hers Board of Directors to help the company increase access to health and wellness solutions Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading hea...
2024-07-20 09:00:00 ET With shares up a blistering 150% year to date, Hims & Hers Health (NYSE: HIMS) boasts everything an investor could dream of these days: rapid expansion, a vast addressable market, and a reasonable valuation. Let's explore why it is my top growth ...
Hims & Hers Health, Inc. ("Hims & Hers") (NYSE: HIMS), the leading health and wellness platform, today announced that it will report second quarter financial results after the market closes on Monday, August 5, 2024. The company will host a live conference call to discuss the results at 5...